公开(公告)号：US09375210B2

公开(公告)日：2016-06-28

申请号：US14735034

申请日：2015-06-09

Applicant: Edwards Lifesciences Corporation

Inventor： Stanton J. Rowe ,  Ming H. Wu ,  Ralph Schneider ,  Philip P. Corso, Jr.

IPC: A61B1/00 ,  A61B17/00 ,  A61B17/02 ,  A61B17/34

CPC classification number: A61B17/0057 ,  A61B17/00234 ,  A61B17/02 ,  A61B17/0293 ,  A61B17/3478 ,  A61B2017/00243 ,  A61B2017/00247 ,  A61B2017/00579 ,  A61B2017/00592 ,  A61B2017/00597 ,  A61B2017/00601 ,  A61B2017/00606 ,  A61B2017/00623 ,  A61B2017/00628 ,  A61B2017/00637 ,  A61B2017/00668 ,  A61B2017/00867 ,  A61B2017/00991 ,  A61B2017/0237 ,  A61B2017/3425

Abstract: A device, system, and method for providing access to, and sealing of, a body organ includes an implant device. An implant device has a main body having an internal access lumen, with a plurality of prongs extending from a distal end of the main body. The main body can include two lumens, one slidable within the other, to form a single continuous lumen with an adjustable length. The main body has an expanded configuration with an expanded diameter, and an unexpanded configuration with an unexpanded diameter. The prongs have a generally straight configuration where they extend distally of the distal end of the main body, and a bent configuration where the prongs bend around so that their tips extend proximally of the distal end of the main body. The device may include a hemostatic barrier to prevent fluid leakage therethrough when the main body is in the unexpanded configuration.

公开(公告)号：US11696827B2

公开(公告)日：2023-07-11

申请号：US17455207

申请日：2021-11-16

Applicant: Edwards Lifesciences Corporation

Inventor： Christopher J. Olson ,  Glen T. Rabito ,  Dustin P. Armer ,  Minh T. Ma ,  Devin H. Marr ,  Cheng-Tung Huang ,  Hiroshi Okabe ,  Kevin M. Stewart ,  Alison S. Curtis ,  Philip P. Corso, Jr.

IPC: A61F2/24

CPC classification number: A61F2/2439 ,  A61F2/243 ,  A61F2/2418 ,  A61F2/2433 ,  A61F2/2436 ,  A61F2/2427 ,  A61F2220/005 ,  A61F2220/0016 ,  A61F2220/0075 ,  A61F2230/0054 ,  A61F2230/0076 ,  A61F2250/006

Abstract: Disclosed herein are representative embodiments of methods, apparatus, and systems used to deliver a prosthetic heart valve assembly. In embodiments, a prosthetic heart valve assembly, including a self-expandable support structure and a self-expanding heart valve, are advanced through the aortic arch of a patient using a delivery system. The support structure, which includes a plurality leaflet retaining arms, is at least partially expanded and positioned on or adjacent to the outflow side of the aortic valve. The prosthetic heart valve is positioned in the aortic valve. The prosthetic heart valve is expanded while it is within an interior of the support structure and while the support structure is positioned on or adjacent to the outflow side of the aortic valve, thereby causing one or more native leaflets of the aortic valve to be frictionally secured between the arms of the support structure and the expanded prosthetic heart valve.

公开(公告)号：US11969344B2

公开(公告)日：2024-04-30

申请号：US16708267

申请日：2019-12-09

Applicant: Edwards Lifesciences Corporation

Inventor： Christopher J. Olson ,  Glen T. Rabito ,  Dustin P. Armer ,  Minh T. Ma ,  Devin H. Marr ,  Cheng-Tung Huang ,  Hiroshi Okabe ,  Kevin M. Stewart ,  Alison S. Curtis ,  Philip P. Corso, Jr.

IPC: A61F2/24

CPC classification number: A61F2/2439 ,  A61F2/2418 ,  A61F2/243 ,  A61F2/2433 ,  A61F2/2436 ,  A61F2/2427 ,  A61F2220/0016 ,  A61F2220/005 ,  A61F2220/0075 ,  A61F2230/0054 ,  A61F2230/0076 ,  A61F2250/006

Abstract: Disclosed herein are representative embodiments of methods, apparatus, and systems used to deliver a prosthetic heart valve to a deficient valve. In one embodiment, for instance, a support structure and an expandable prosthetic valve are advanced through the aortic arch of a patient using a delivery system. The support structure is delivered to a position on or adjacent to the surface of the outflow side of the aortic valve (the support structure defining a support-structure interior). The expandable prosthetic valve is delivered into the aortic valve and into the support-structure interior. The expandable prosthetic heart valve is expanded while the expandable prosthetic heart valve is in the support-structure interior and while the support structure is at the position on or adjacent to the surface of the outflow side of the aortic valve, thereby causing one or more native leaflets of the aortic valve to be frictionally secured between the support structure and the expanded prosthetic heart valve.